Diseases, Conditions, Syndromes

New Ebola vaccine faces key test

The experimental Ebola vaccine dubbed rVSV-ZEBOV has shown promising signs that it can contain the spread of the prolific killer virus.

Diseases, Conditions, Syndromes

Ebola: Early immune response provides insight into vaccination

The latest outbreaks of emerging, dangerous pathogens, such as Ebola, MERS-CoV or Zika, emphasise the importance of the rapid development of effective vaccines. However, being able to predict the efficacy of new vaccines ...

Diseases, Conditions, Syndromes

Ebola vaccine developed in Canada shows promising results

A phase 1 randomized controlled trial has found an Ebola virus disease (EVD) vaccine, developed in Canada, was well-tolerated with no safety concerns, and high antibodies were present in participants 6 months after immunization. ...

Diseases, Conditions, Syndromes

Early blood signatures of vaccine immunogenicity

Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect. This is one of the results of a new study from a large European ...

Diseases, Conditions, Syndromes

Vet research identifies new target for taming Ebola

Viruses and their hosts are in a eternal game of one-upmanship. If a host cell evolves a way to stop a virus from spreading, the virus will look for a new path. And so on and so forth.

page 1 from 3